MYC and central nervous system cancer: Inhibition of GSK-3 activity induces phosphorylation of c-Myc site S62 and results in increased expression of apoptosis-related Bax, Bim, DR4/DR5, and TRAIL expression and subsequent cytotoxicity and apoptosis of glioma cells.